Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in children and individuals. In Canada, its availability is strictly regulated by https://vyvanseincanada982917.itbloghub.com/551642/this-medication-in-canada-a-detailed-guide